Drug intelligence / Profile preview

Befact Duo

Development stage: Unknown
Lead developer: SMB Laboratoires
Modality: Small Molecules
Administration: Oral

Overview

Befact Duo is an over-the-counter (OTC) nutritional supplement developed by the Belgian pharmaceutical company Laboratoires SMB. It is formulated as an oral chewable tablet containing a combination of Vitamin B9 (400 µg of folic acid) and Vitamin B12 (660 µg). The Vitamin B12 component is provided in two active forms: hydroxocobalamin and methylcobalamin. The product is indicated for the support of brain function, the nervous system, and normal psychological function. As a vitamin supplement, it serves as a nutritional support product for individuals requiring B-vitamin supplementation and does not have a specific biological target in the traditional pharmaceutical sense.

Brand names: Befact Duo
Other names: Befact

Beyond the preview

Go deeper on Befact Duo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Befact Duo.

Explore the full profile